ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 148 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $56,376 | +26.2% | 2,753 | +22.4% | 0.00% | – |
Q2 2023 | $44,668 | +30.5% | 2,249 | +12.5% | 0.00% | – |
Q1 2023 | $34,224 | -9.4% | 1,999 | +4.0% | 0.00% | – |
Q4 2022 | $37,795 | +1159.8% | 1,923 | +861.5% | 0.00% | – |
Q3 2022 | $3,000 | -25.0% | 200 | -18.4% | 0.00% | – |
Q2 2022 | $4,000 | 0.0% | 245 | -14.6% | 0.00% | – |
Q1 2022 | $4,000 | -33.3% | 287 | -7.1% | 0.00% | – |
Q4 2021 | $6,000 | -25.0% | 309 | +12.0% | 0.00% | – |
Q3 2021 | $8,000 | -33.3% | 276 | 0.0% | 0.00% | – |
Q2 2021 | $12,000 | -25.0% | 276 | -26.2% | 0.00% | – |
Q1 2021 | $16,000 | +23.1% | 374 | +61.9% | 0.00% | – |
Q4 2020 | $13,000 | +1200.0% | 231 | +645.2% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 31 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | – | 31 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 31 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |